Humatica appoints new Partner in the Zurich office

ndetails

Dr. Jochen Schilcher has been appointed as a new Partner to support Humatica’s continued growth. He will begin on 1. October and be based out of the Zurich office.

Dr. Schilcher has over 20 years of management consulting experience with leading global consultants including Booz & Co. and Oliver Wyman. During this time, he advised international clients on a wide range of topics including strategy-driven organizational development and efficiency improvement driven by changing market conditions. He assisted leading global private equity firms and their portfolio companies with pre-closing due diligence, post-acquisition transformation, bolt-on investments/PMI and exit preparation.

Andros Payne, Founder and Managing Partner of Humatica, notes: “I am thrilled that Jochen is joining Humatica. We have ambitious international growth plans, and his extensive consulting and thematic expertise in developing high performance organizations will help us to better serve existing clients and develop new relationships.”

Jochen Schilcher adds: “Andros and I have known each other for 25 years. In my early consulting career we worked closely on diverse value growth projects in the corporate and private equity sectors. I am pleased to join the entrepreneurial Humatica team and contribute to its exciting growth story.

Jochen graduated in Business Economics with a major in Strategy and Organizations from the University of St. Gallen (HSG). He also received his doctorate degree on the specific challenges of high-tech ventures in marketing technological innovations.

To download the news release in PDF format, click here.

Related News

Humatica announces senior promotions in London and Zurich
01 Apr, 2026 By Humatica

Humatica announces senior promotions in London and Zurich

Humatica is pleased to announce two senior level promotions, reflecting continued growth and the strengthening of its leadership team. Paul Simpson, based in Zurich, has…

Read more arrowicon
Humatica once again recognised as a leader in private equity value creation by Actum in its 2026 awards
27 Jan, 2026 By Humatica

Humatica once again recognised as a leader in private equity value creation by Actum in its 2026 awards

Humatica has once again been short-listed for Actum’s 2026 Value Creation Award in the People & Organisational Strategy category. This recognition reflects Humatica’s 23‑year commitment…

Read more arrowicon
Humatica is again finalist for prestigious Real Deals Award
16 Jan, 2026 By Humatica

Humatica is again finalist for prestigious Real Deals Award

Humatica is once again shortlisted for Real Deals’ prestigious Private Equity Awards 2026 in the “Value Creation Adviser of the Year” category. This recognition underscores…

Read more arrowicon